Bookmark and Share

Compound Summary for: CID 213053

cimicoxib

Also known as: UNII-W7FHJ107MC; UR-8880; CHEMBL435381; CHEBI:76127; 265114-23-6; 4-(4-chloro-5-(3-fluoro-4-methoxyphenyl)imidazol-1-yl)benzenesulfonamide
Molecular Formula: C16H13ClFN3O3S   Molecular Weight: 381.809123   InChIKey: KYXDNECMRLFQMZ-UHFFFAOYSA-N
Cimicoxib is a selective COX-2 inhibitor being developed by Affectis as a treatment for depression and schizophrenia. If approved, Cimicoxib would be the first drug in decades to treat depression by a new mechanism of action.   From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _